(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.

Sharon Osborne sparked surgery concern once again this week as she stepped out in LA on Wednesday with a noticeably more taut ...

People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can ...

A new spate of weight loss drugs like Ozempic and Wegovy is surging in popularity, but health experts caution they're not for ...

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

A significant update includes the incorporation of new weight loss drugs, which have been shown to not only reduce weight but ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.'s latest push into healthcare will disrupt Hims & Hers' business.